The estimated Net Worth of Samarth Kulkarni is at least $39,789,128.16. Samarth Kulkarni owns over 182,989 units of CRISPR Therapeutics AG stock worth over $39,789,128.16.
| Transaction Date | Company | Shares | Type | Owned | Price | Value | Post Value |
|---|---|---|---|---|---|---|---|
| 15th January 2021 | CRSP - CRISPR Therapeutics AG | 1,304 | Open or private sale | 182,989 | $217.44 | $283,541.76 | $39,789,128.16 |
| 15th January 2021 | CRSP - CRISPR Therapeutics AG | 1,708 | Open or private sale | 184,293 | $216.50 | $369,782.00 | $39,899,434.50 |
| 15th January 2021 | CRSP - CRISPR Therapeutics AG | 1,700 | Open or private sale | 186,001 | $214.68 | $364,956.00 | $39,930,694.68 |
| 15th January 2021 | CRSP - CRISPR Therapeutics AG | 5,623 | Open or private sale | 187,701 | $213.71 | $1,201,691.33 | $40,113,580.71 |
| 15th January 2021 | CRSP - CRISPR Therapeutics AG | 6,525 | Open or private sale | 193,324 | $212.75 | $1,388,193.75 | $41,129,681.00 |
| 15th January 2021 | CRSP - CRISPR Therapeutics AG | 3,140 | Open or private sale | 199,849 | $211.83 | $665,146.20 | $42,334,013.67 |
| 15th January 2021 | CRSP - CRISPR Therapeutics AG | 20,000 | Exercise of derivative | 202,989 | $1.81 | $36,200.00 | $367,410.09 |
| 29th December 2020 | CRSP - CRISPR Therapeutics AG | 13,800 | Exercise of derivative | 182,989 | $1.81 | $24,978.00 | $331,210.09 |
| 10th December 2020 | CRSP - CRISPR Therapeutics AG | 600 | Open or private sale | 169,189 | $144.97 | $86,982.00 | $24,527,329.33 |
| 10th December 2020 | CRSP - CRISPR Therapeutics AG | 2,100 | Open or private sale | 169,789 | $143.71 | $301,791.00 | $24,400,377.19 |
| 10th December 2020 | CRSP - CRISPR Therapeutics AG | 6,766 | Open or private sale | 171,889 | $142.75 | $965,846.50 | $24,537,154.75 |
| 10th December 2020 | CRSP - CRISPR Therapeutics AG | 5,034 | Open or private sale | 178,655 | $141.98 | $714,727.32 | $25,365,436.90 |
| 10th December 2020 | CRSP - CRISPR Therapeutics AG | 5,500 | Open or private sale | 183,689 | $141.17 | $776,435.00 | $25,931,376.13 |
| 10th December 2020 | CRSP - CRISPR Therapeutics AG | 20,000 | Exercise of derivative | 189,189 | $1.81 | $36,200.00 | $342,432.09 |
| 1st December 2020 | CRSP - CRISPR Therapeutics AG | 779 | Payment by withholding | 169,189 | $129.58 | $100,942.82 | $21,923,510.62 |
| 1st March 2019 | CRSP - CRISPR Therapeutics AG | 748 | Payment by withholding | 166,542 | $39.97 | $29,897.56 | $6,656,683.74 |
| 29th April 2019 | CRSP - CRISPR Therapeutics AG | 20,000 | Open or private sale | 166,542 | $42.03 | $840,600.00 | $6,999,760.26 |
| 29th April 2019 | CRSP - CRISPR Therapeutics AG | 20,000 | Exercise of derivative | 186,542 | $1.81 | $36,200.00 | $337,641.02 |
| 1st June 2019 | CRSP - CRISPR Therapeutics AG | 741 | Payment by withholding | 165,801 | $35.57 | $26,357.37 | $5,897,541.57 |
| 17th June 2019 | CRSP - CRISPR Therapeutics AG | 20,000 | Open or private sale | 165,801 | $46.00 | $920,000.00 | $7,626,846.00 |
| 17th June 2019 | CRSP - CRISPR Therapeutics AG | 20,000 | Exercise of derivative | 185,801 | $1.81 | $36,200.00 | $336,299.81 |
| 1st September 2019 | CRSP - CRISPR Therapeutics AG | 740 | Payment by withholding | 165,061 | $46.21 | $34,195.40 | $7,627,468.81 |
| 1st December 2019 | CRSP - CRISPR Therapeutics AG | 741 | Payment by withholding | 164,320 | $71.65 | $53,092.65 | $11,773,528.00 |
| 16th December 2019 | CRSP - CRISPR Therapeutics AG | 8,000 | Exercise of derivative | 172,320 | $1.81 | $14,480.00 | $311,899.20 |
| 2nd March 2020 | CRSP - CRISPR Therapeutics AG | 794 | Payment by withholding | 171,526 | $52.74 | $41,875.56 | $9,046,281.24 |
| 20th May 2020 | CRSP - CRISPR Therapeutics AG | 10,693 | Open or private sale | 171,526 | $65.28 | $698,039.04 | $11,197,217.28 |
| 20th May 2020 | CRSP - CRISPR Therapeutics AG | 10,693 | Exercise of derivative | 182,219 | $1.81 | $19,354.33 | $329,816.39 |
| 19th May 2020 | CRSP - CRISPR Therapeutics AG | 4,307 | Open or private sale | 171,526 | $65.16 | $280,644.12 | $11,176,634.16 |
| 19th May 2020 | CRSP - CRISPR Therapeutics AG | 4,307 | Exercise of derivative | 175,833 | $1.81 | $7,795.67 | $318,257.73 |
| 2nd June 2020 | CRSP - CRISPR Therapeutics AG | 779 | Payment by withholding | 170,747 | $66.26 | $51,616.54 | $11,313,696.22 |
| 1st June 2020 | CRSP - CRISPR Therapeutics AG | 5,575 | Open or private sale | 171,526 | $65.26 | $363,824.50 | $11,193,786.76 |
| 1st June 2020 | CRSP - CRISPR Therapeutics AG | 9,300 | Open or private sale | 177,101 | $64.61 | $600,873.00 | $11,442,495.61 |
| 1st June 2020 | CRSP - CRISPR Therapeutics AG | 2,400 | Open or private sale | 186,401 | $63.57 | $152,568.00 | $11,849,511.57 |
| 1st June 2020 | CRSP - CRISPR Therapeutics AG | 17,275 | Exercise of derivative | 188,801 | $1.81 | $31,267.75 | $341,729.81 |
| 2nd September 2020 | CRSP - CRISPR Therapeutics AG | 779 | Payment by withholding | 169,968 | $94.15 | $73,342.85 | $16,002,487.20 |